EU Mid-Market Update: US markets technically return from Thanksgiving but volume indicates a long-weekend for most; Data driven EU session fails to move needles ahead of S&P decision on France.
Pfizer said the green light makes Hympavzi the first once-weekly subcutaneous treatment in the European Union for people with severe hemophilia B and the first to be administered via a pre-filled pen ...